JP2003511550A5 - - Google Patents

Download PDF

Info

Publication number
JP2003511550A5
JP2003511550A5 JP2001531088A JP2001531088A JP2003511550A5 JP 2003511550 A5 JP2003511550 A5 JP 2003511550A5 JP 2001531088 A JP2001531088 A JP 2001531088A JP 2001531088 A JP2001531088 A JP 2001531088A JP 2003511550 A5 JP2003511550 A5 JP 2003511550A5
Authority
JP
Japan
Prior art keywords
composition
polyanhydride
iii
formula
hydroxy acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001531088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003511550A (ja
Filing date
Publication date
Priority claimed from US09/422,294 external-priority patent/US6468519B1/en
Application filed filed Critical
Publication of JP2003511550A publication Critical patent/JP2003511550A/ja
Publication of JP2003511550A5 publication Critical patent/JP2003511550A5/ja
Pending legal-status Critical Current

Links

JP2001531088A 1999-10-21 2000-10-11 生物学的に活性な分解産物を有するポリ酸無水物 Pending JP2003511550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/422,294 US6468519B1 (en) 1997-09-10 1999-10-21 Polyanhydrides with biologically active degradation products
US09/422,294 1999-10-21
PCT/US2000/027962 WO2001028492A2 (en) 1999-10-21 2000-10-11 Polyanhydrides with biologically active degradation products

Publications (2)

Publication Number Publication Date
JP2003511550A JP2003511550A (ja) 2003-03-25
JP2003511550A5 true JP2003511550A5 (US20040106767A1-20040603-C00005.png) 2007-11-29

Family

ID=23674230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001531088A Pending JP2003511550A (ja) 1999-10-21 2000-10-11 生物学的に活性な分解産物を有するポリ酸無水物

Country Status (9)

Country Link
US (2) US6468519B1 (US20040106767A1-20040603-C00005.png)
EP (2) EP1246627B1 (US20040106767A1-20040603-C00005.png)
JP (1) JP2003511550A (US20040106767A1-20040603-C00005.png)
AT (1) ATE314078T1 (US20040106767A1-20040603-C00005.png)
AU (1) AU7877100A (US20040106767A1-20040603-C00005.png)
CA (1) CA2387558A1 (US20040106767A1-20040603-C00005.png)
DE (1) DE60025272D1 (US20040106767A1-20040603-C00005.png)
MX (1) MXPA02003890A (US20040106767A1-20040603-C00005.png)
WO (1) WO2001028492A2 (US20040106767A1-20040603-C00005.png)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US7985415B2 (en) * 1997-09-10 2011-07-26 Rutgers, The State University Of New Jersey Medical devices employing novel polymers
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7122615B1 (en) 1998-09-10 2006-10-17 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
EP2095817A1 (en) * 1999-12-07 2009-09-02 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US6527801B1 (en) 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
CA2771263A1 (en) * 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
US6602915B2 (en) 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
MXPA04004701A (es) * 2001-11-23 2005-07-01 Univ Rutgers Sintesis mejorada de polianhidridos.
US20040096476A1 (en) * 2002-07-17 2004-05-20 Uhrich Kathryn E. Therapeutic devices for patterned cell growth
US6932930B2 (en) * 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
US9445901B2 (en) * 2003-03-12 2016-09-20 Deger C. Tunc Prosthesis with sustained release analgesic
EP1626748B1 (en) * 2003-05-13 2012-07-11 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
US20050249697A1 (en) * 2003-09-24 2005-11-10 Uhrich Kathryn E Compositions and methods for the inhibition of bone growth and resorption
US8352712B2 (en) * 2004-05-06 2013-01-08 International Business Machines Corporation Method and system for specualtively sending processor-issued store operations to a store queue with full signal asserted
JP5247144B2 (ja) * 2004-05-14 2013-07-24 インターフェース バイオロジクス インコーポレーティッド 高分子カップリング剤およびそれらから製造された薬学的に活性のあるポリマー
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US7858077B2 (en) * 2005-01-28 2010-12-28 Bezwada Biomedical Llc Functionalized phenolic esters and amides and polymers therefrom
US7691364B2 (en) * 2005-01-28 2010-04-06 Bezwada Biomedical, Llc Functionalized drugs and polymers derived therefrom
US20060193891A1 (en) * 2005-02-25 2006-08-31 Robert Richard Medical devices and therapeutic delivery devices composed of bioabsorbable polymers produced at room temperature, method of making the devices, and a system for making the devices
EP1898832A4 (en) * 2005-05-23 2013-01-02 Univ Rutgers RAPIDLY DEGRADING POLYMERS
WO2007053794A2 (en) * 2005-10-21 2007-05-10 Bezwada Biomedical Llc Functionalized phenolic compounds and absorbable therefrom
US8007526B2 (en) 2005-12-01 2011-08-30 Bezwada Biomedical, Llc Difunctionalized aromatic compounds and polymers therefrom
US7935843B2 (en) * 2005-12-09 2011-05-03 Bezwada Biomedical, Llc Functionalized diphenolics and absorbable polymers therefrom
US9603941B2 (en) * 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
US20070225472A1 (en) * 2006-03-23 2007-09-27 Varshney Sunil K Polyanhydride polymers and their uses in biomedical devices
EP2032614A2 (en) * 2006-06-06 2009-03-11 Rutgers, The State University Of New Jersey Iodinated polymers
WO2008034019A2 (en) 2006-09-13 2008-03-20 Polymerix Corporation Active agents and their oligomers and polymers
EP2077861A2 (en) * 2006-10-23 2009-07-15 Bioabsorbable Therapeutics, Inc. A drug-release composition having a therapeutic carrier
EP2066294B9 (en) * 2006-11-06 2013-04-10 Whitehead Institute Immunomodulating compositions and methods of use thereof
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
US8747832B2 (en) * 2007-04-12 2014-06-10 Rutgers, The State University Of New Jersey Biodegradable polyanhydrides with natural bioactive molecules
US8217134B2 (en) 2007-08-30 2012-07-10 Bezwada Biomedical, Llc Controlled release of biologically active compounds
US8026285B2 (en) 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
WO2010148104A2 (en) * 2009-06-16 2010-12-23 L'oreal S.A. Topical compositions containing a polymer for releasing at least one salicylic acid compound
WO2010148101A2 (en) * 2009-06-16 2010-12-23 L'oreal S.A. Topical compositions containing a polymer for releasing at least one salicylic acid compound
US8741317B2 (en) 2010-08-19 2014-06-03 Rutgers, The State University Of New Jersey Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
WO2014194055A1 (en) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
WO2015191742A1 (en) 2014-06-13 2015-12-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
WO2016164898A1 (en) 2015-04-10 2016-10-13 Rutgers, The State University Of New Jersey Kojic acid polymers
CA3087898A1 (en) 2018-02-02 2019-08-08 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE288387C (US20040106767A1-20040603-C00005.png)
DE288311C (US20040106767A1-20040603-C00005.png) 1915-10-27
US4062855A (en) 1971-09-27 1977-12-13 University Of Washington Synthetic polymers furnishing controlled release of a biologically active component during degradation
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4287174A (en) * 1978-03-31 1981-09-01 The Proctor & Gamble Company Anti-ulcer composition
US4298595A (en) * 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4483854A (en) * 1983-04-12 1984-11-20 Key Pharmaceuticals, Inc. Systemic treatment of psoriasis using certain salicylates
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4612302A (en) 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4684620A (en) 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
CH666185A5 (en) * 1985-09-16 1988-07-15 Dieter Dr Russmann Salicylic acid or sodium salt - used for treating inflammatory intestinal disorders
CH671402A5 (US20040106767A1-20040603-C00005.png) 1985-10-02 1989-08-31 Sandoz Ag
DE3670206D1 (de) 1986-05-20 1990-05-17 Massachusetts Inst Technology Bioerodierbare erzeugnisse zur verwendung als implantate oder prothese mit einem voraussehbaren resorbierungsgrad.
US6024983A (en) 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5055524A (en) * 1987-07-16 1991-10-08 Ppg Industries, Inc. Polyol-modified polyanhydride curing agent for polyepoxide powder coatings
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US5259968A (en) 1988-02-29 1993-11-09 Exxon Chemical Patents Inc. Dispersant additive comprising the reaction product of a polyanhydride and a mannich condensation product
US4868274A (en) 1988-05-23 1989-09-19 Hoechst Celanese Corp. Polyanhydride from carboxy aryloxy alkanoic acid
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
AU5287090A (en) 1989-02-28 1990-09-26 Marc N. Benhuri Method and composition for treatment of periodontal disease
US4999417A (en) 1989-03-30 1991-03-12 Nova Pharmaceutical Corporation Biodegradable polymer compositions
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US4997904A (en) 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
AU655762B2 (en) 1989-12-26 1995-01-12 Nova Pharmaceutical Corporation Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
US5175235A (en) 1990-06-04 1992-12-29 Nova Pharmaceutical Corporation Branched polyanhydrides
US5317079A (en) * 1990-01-19 1994-05-31 Nova Pharmaceutical Corporation Fatty acid terminated polyanhydride
NL9000237A (nl) 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
US5082925A (en) 1990-08-16 1992-01-21 Ethicon, Inc. Homopolymers and copolymers of salicylate lactones
ATE152147T1 (de) 1990-11-19 1997-05-15 Cornell Res Foundation Inc Hyperverzweigte polyester
US5198572A (en) * 1991-02-04 1993-03-30 General Electric Company Copolymers of dicarboxylic acids and salicylic acids
US5151415A (en) * 1991-05-23 1992-09-29 Dallas Sirany Method of treating a papova-type viral infection
US5264540A (en) 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
KR100481565B1 (ko) * 1994-07-22 2005-09-30 꼴레띠까 친유성히드록시산,그의화장제및약제학적용도및그의제조방법
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
WO1997029778A2 (en) * 1996-02-15 1997-08-21 Santerre J Paul Bioresponsive pharmacologically-active polymers and articles made therefrom
US5837680A (en) * 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US5902599A (en) 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
JP4410857B2 (ja) 1997-02-18 2010-02-03 ラットガーズ ザ ステイト ユニヴァーシティ ヒドロキシ酸から誘導されたモノマー及びそれから調製されたポリマー
WO1999007382A1 (en) * 1997-08-06 1999-02-18 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
ATE378364T1 (de) 1997-09-10 2007-11-15 Univ Rutgers Polyamhydride mit therapeutisch verwendbaren abbauprodukten
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
DE19754063A1 (de) 1997-12-05 1999-06-10 Bayer Ag Abbau von biologisch abbaubaren Polymeren
US6060212A (en) * 1998-06-11 2000-05-09 Clariant Finance (Bvi) Limited 193 nm positive-working photoresist composition
US6153212A (en) * 1998-10-02 2000-11-28 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
US6602915B2 (en) * 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
CA2771263A1 (en) * 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
US20040096476A1 (en) * 2002-07-17 2004-05-20 Uhrich Kathryn E. Therapeutic devices for patterned cell growth

Similar Documents

Publication Publication Date Title
JP2003511550A5 (US20040106767A1-20040603-C00005.png)
JP2002533472A5 (US20040106767A1-20040603-C00005.png)
EP1702597A3 (en) Drug delivery of phase changing formulation
ES2189874T3 (es) Dinucleotidos utiles para el tratamiento de enfermedades pulmonares.
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
JP2002519434A5 (US20040106767A1-20040603-C00005.png)
EP1153924A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
ATE390414T1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
CY2575B1 (en) Improved denture adhesive composition
EP2289521A3 (en) Compositions and methods for use in tergeting vascular destruction
JP2003530368A5 (US20040106767A1-20040603-C00005.png)
JP2005519985A5 (US20040106767A1-20040603-C00005.png)
PL362208A1 (en) Rhinological agents
JP2002518170A5 (US20040106767A1-20040603-C00005.png)
JP2003532640A5 (US20040106767A1-20040603-C00005.png)
JP2003509360A5 (US20040106767A1-20040603-C00005.png)
JP2002506864A5 (US20040106767A1-20040603-C00005.png)
JP2003520208A5 (US20040106767A1-20040603-C00005.png)
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
JP2002540119A5 (US20040106767A1-20040603-C00005.png)
JP2003521457A5 (US20040106767A1-20040603-C00005.png)
EP1149826A3 (en) Ester compounds having alicyclic structure, and methods for preparing the same
EP0308983A3 (en) Nmr imaging with mn(ii) coordination compositions
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
JPH0597697A (ja) 歯槽骨再生剤